TipRanks
Neuren Pharmaceuticals Limited (NURPF)
OTHER OTC:NURPF
US Market
NURPF
Neuren Pharmaceuticals Limited
RESEARCH TOOLSreports

Neuren Pharmaceuticals Limited (NURPF) Ratios

55 Followers

Neuren Pharmaceuticals Limited Ratios

NURPF's free cash flow for Q2 2026 was AU$1.00. For the 2026 fiscal year, NURPF's free cash flow was decreased by AU$ and operating cash flow was AU$0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 46.45 76.60 8.73 5.78 25.77
Quick Ratio
 46.45 76.60 8.73 5.78 25.77
Cash Ratio
 3.75 0.97 0.07 0.40 23.95
Solvency Ratio
 2.80 6.91 3.10 3.67 0.12
Operating Cash Flow Ratio
 0.71 28.92 -0.25 4.32 2.14
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
AU$ 326.26MAU$ 327.83MAU$ 353.52MAU$ 204.39MAU$ 41.57M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.02 1.01 1.13 1.21 1.04
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
 -1.94 -0.19 -0.02 -0.09 59.97
Profitability Margins
Gross Profit Margin
99.96%99.96%99.99%88.47%99.93%
EBIT Margin
19.92%34.07%82.32%85.89%-4.67%
EBITDA Margin
19.96%34.11%82.33%85.92%-4.60%
Operating Profit Margin
19.92%34.07%82.32%74.37%-10.97%
Pretax Profit Margin
38.57%60.23%85.79%88.45%-4.67%
Net Profit Margin
29.14%47.09%66.61%67.73%1.26%
Continuous Operations Profit Margin
29.14%47.09%66.61%67.73%1.26%
Net Income Per EBT
75.55%78.18%77.64%76.57%-27.06%
EBT Per EBIT
193.64%176.76%104.21%118.93%42.61%
Return on Assets (ROA)
5.95%8.88%34.67%63.35%0.43%
Return on Equity (ROE)
6.03%8.99%39.03%76.55%0.44%
Return on Capital Employed (ROCE)
4.15%6.51%48.24%84.06%-3.84%
Return on Invested Capital (ROIC)
3.14%5.09%37.45%64.37%1.04%
Return on Tangible Assets
5.95%8.88%34.67%63.35%0.43%
Earnings Yield
0.79%1.28%8.89%4.98%0.02%
Efficiency Ratios
Receivables Turnover
 2.09 2.44 1.23 16.09 13.36
Payables Turnover
 <0.01 0.03 0.02 39.63 0.04
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 1.83K 1.44K 6.88K 5.39K 693.00
Asset Turnover
 0.20 0.19 0.52 0.94 0.34
Working Capital Turnover Ratio
 0.21 0.19 0.76 1.89 0.36
Cash Conversion Cycle
 -100.61K -13.77K -23.74K 13.47 -9.39K
Days of Sales Outstanding
 175.04 149.89 295.96 22.68 27.31
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 100.78K 13.92K 24.04K 9.21 9.42K
Operating Cycle
 175.04 149.89 295.96 22.68 27.31
Cash Flow Ratios
Operating Cash Flow Per Share
 0.04 0.98 -0.09 1.46 0.03
Free Cash Flow Per Share
 0.04 0.98 -0.09 1.45 0.03
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.99 1.00 1.00 1.00 0.99
Dividend Paid and CapEx Coverage Ratio
 127.93 3.39K -1.13K 4.62K 189.42
Capital Expenditure Coverage Ratio
 127.93 3.39K -1.13K 4.62K 189.42
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.07 1.94 -0.05 0.80 0.25
Free Cash Flow Yield
0.20%5.25%-0.71%5.86%0.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 128.11 77.54 11.26 20.08 5.44K
Price-to-Sales (P/S) Ratio
 36.99 36.92 7.49 13.60 68.81
Price-to-Book (P/B) Ratio
 7.71 7.05 4.39 15.37 24.08
Price-to-Free Cash Flow (P/FCF) Ratio
 506.40 19.03 -141.59 17.06 279.73
Price-to-Operating Cash Flow Ratio
 502.44 19.03 -141.71 17.05 278.25
Price-to-Earnings Growth (PEG) Ratio
 -1.49 -0.99 -1.07 <0.01 -53.22
Price-to-Fair Value
 7.71 7.05 4.39 15.37 24.08
Enterprise Value Multiple
 183.38 108.06 9.08 15.74 -1.43K
Enterprise Value
 2.54B 2.38B 1.59B 3.14B 961.25M
EV to EBITDA
 183.38 108.06 9.08 15.74 -1.43K
EV to Sales
 36.60 36.86 7.47 13.52 66.05
EV to Free Cash Flow
 501.09 19.00 -141.31 16.97 268.50
EV to Operating Cash Flow
 497.17 18.99 -141.43 16.96 267.09
Tangible Book Value Per Share
 2.63 2.64 2.85 1.61 0.33
Shareholders’ Equity Per Share
 2.63 2.64 2.85 1.61 0.33
Tax and Other Ratios
Effective Tax Rate
 0.24 0.22 0.22 0.23 1.27
Revenue Per Share
 0.55 0.50 1.67 1.83 0.12
Net Income Per Share
 0.16 0.24 1.11 1.24 <0.01
Tax Burden
 0.76 0.78 0.78 0.77 -0.27
Interest Burden
 1.94 1.77 1.04 1.03 1.00
Research & Development to Revenue
 0.70 0.56 0.15 0.12 0.87
SG&A to Revenue
 0.10 0.10 0.02 0.03 0.24
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.14
Income Quality
 0.25 4.12 -0.08 1.18 19.56
Currency in AUD